Menu
  • Video
  • Audio
  • Images
  • Collections
  • About
Sign in
ASRS A project from the American Soceity of Retina Specialists
Share feedback      Sign in
ASRS Multimedia Library
ASRS A project from the American Society of Retina Specialists
Search by condition, keyword, or author name
  • Video
  • Audio
  • Images
  • Collections
  • About
  1. Collections
  2. Updates from the Field

Sign in to view content

Sign in

Efficacy, Safety, and Durability of Faricimab in Diabetic Macular Edema (DME): One-Year Results From the Phase 3 YOSEMITE and RHINE Trials

  • Caroline Baumal, MD
  • Video
  • Published 2021

Related

  • Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch

    Estephania Feria, MD

    On Demand Cases, Courses, and Papers

    2019

  • The Evolving Treatment of Proliferative Diabetic Retinopathy: The Diabetic Retinopathy Study to the DRCR Protocol S

    Timothy W. Olsen, MD

    Webinars and Journal Clubs

    2016

  • Progression of diabetic retinopathy in patients treated with 0.2 μg/day

    Raymond Iezzi, MD, MS

    Updates from the Field

    2017

Category: Diabetic Retinopathy

  • Diabetic Macular Edema
  • Faricimab
  • Phase 3 Trial
  • Angiopoietin-2
  • VEGF-A

See more

  • Updates from the Field
  • Caroline Baumal, MD
  • ASRS Multimedia Library
  • Video
  • Audio
  • Images
  • Collections
American Society of Retina Specialists20 North Wacker Drive, Suite 2030,Chicago, Illinois 60606(312) 578-8760 phoneinfo@asrs.org
© 2025 The American Society of Retina Specialists. All rights reserved. Privacy statement. Terms of use.